Body
WASHINGTON--The Endocrine Society and Avalere Health introduced the first-ever quality measures to help healthcare providers assess how well they identify and care for older adults at greater risk of hypoglycemia--low blood sugar that can be a dangerous complication of diabetes treatment.
Fewer than 10% of dermatologists practice in rural areas, according to the Journal of the American Academy of Dermatology. That means primary care physicians (PCPs) are often relied upon to diagnose skin cancers in areas where access to dermatologists is lacking, even though multiple studies have shown most PCPs do not feel adequately prepared to diagnose and treat many skin conditions.
COLUMBUS, Ohio - The out-of-pocket financial burden for insured working Americans is substantial and growing - especially when it comes to out-of-network, non-emergency hospital care, a new study has found.
Researchers at The Ohio State University analyzed claims from more than 22 million enrollees in private insurance plans and found that out-of-pocket costs for non-emergency out-of-network hospital care nearly doubled in five years.
Statement advising caution on interpretation of recent paper on cancer risk & hyperthyroidism issued
Caution is advised in interpreting the findings of the recent JAMA Internal Medicine publication1 on radioactive iodine treatment for hyperthyroid patients and cancer mortality. The paper's conclusion that "in RAI-treated patients with hyperthyroidism, greater organabsorbed doses appeared to be modestly positively associated with risk of death from solid cancer, including breast cancer", has raised concerns among patients and clinicians.
A new, objective way of measuring flavanol intake has been developed, which could help nutritional experts assess the link between these compounds and their health benefits at scale.
In the first study of its kind published in Nature Scientific Reports, researchers at the University of Reading, the University of California Davis and Mars, Incorporated have identified and validated the first biomarkers for flavanol- and procyanidin intake at scale.
SAN ANTONIO, TX - In the updated results from NRG Oncology/NSABP B-42 trial through 10 years of observation, extending letrozole therapy for additional five years after five years of adjuvant endocrine therapy resulted in a statistically significant improvement in the 10-year disease-free survival (DFS) of postmenopausal women with hormone-receptor-positive breast cancer. The study continues to show no difference in overall survival with letrozole compared to placebo. The findings were presented at the 2019 San Antonio Breast Cancer Symposium, held December 10-14.
NEW YORK - Nearly one-quarter of people living with HIV were willing to risk near-certain death in a clinical trial, if volunteering for the trial would help find a cure for the disease, according to the new study "HIV Cure Research." "I am not going to live forever," said one interviewee, "it is about the next man, the next woman, and you have to have the mindset to care about people, which I do." Another interviewee said, "I'm willing to go the course for the cure and for the HIV community.
New research published today in the Journal of Physiology shows that breastfeeding is crucial in preventing diabetes.
The World Health Organization recommends breastfeeding as the sole source of nutrition for infants until six months of age, as this helps reduce child morbidity and mortality. In contrast, early weaning is associated with both the development of obesity and Type 2 diabetes in adulthood.
A team led by researchers at Baylor College of Medicine and Harvard Medical School has unveiled a novel mechanism that helps explain how endocrine-resistant breast cancer acquires metastatic behavior, opening the possibility of new therapeutic strategies.
Published in the Proceedings of the National Academy of Sciences, the study shows that hyperactive FOXA1 signaling, which previously was reported in endocrine-resistant metastatic breast cancer, triggers genome-wide reprogramming that results in enhanced resistance to treatment and metastatic behaviors.
In the last decade, scientists discovered that blocking a key regulator of the immune system helped unleash the body's natural defenses against several forms of cancer, opening up a new era of cancer immunotherapy. Now Yale scientists have essentially flipped this script and found that when impaired a molecularly similar regulator can cause the damaging immune system attacks on skin and organs that are the hallmark of the autoimmune disease lupus, they report Dec. 11 in the journal Science Translational Medicine.
UNIVERSITY PARK, Pa. -- When protesters use social media to attract attention and unify, people in power may respond with tweeting tactics designed to distract and confuse, according to a team of political scientists.
Looking to gain a deeper understanding of cancer, a team led by researchers at Baylor College of Medicine conducted an extensive computational analysis of the similarities and differences in the entire set of proteins, called the proteome, of more than 500 cancers from five different tissue sites. Published in the journal Nature Communications, the work led to the classification of the cancers into 10 subtypes, each including cancers that shared common proteins that seemed to be involved in the disease.
WASHINGTON -- Brain imaging of veterans with Gulf War illness show varying abnormalities after moderate exercise that can be categorized into two distinct groups -- an outcome that suggests a more complex illness that previously thought.
The immune system establishes "forward operating bases", or lymph node-like structures, inside the tumors of some patients with kidney and other urologic cancers, researchers at Winship Cancer Institute of Emory University have discovered.
Patients with chronic pain caught between cardiovascular concerns about non-opioid analgesics and addiction risks of opioids, likely causing significant unmet need for pain relief.